key: cord-0929522-br2xyzfs
authors: Bouslama, Boutheina; Pierret, Clément; Khelfaoui, Fatima; Bellanné‐Chantelot, Christine; Donadieu, Jean; Héritier, Sébastien
title: Post‐COVID‐19 severe neutropenia
date: 2020-12-23
journal: Pediatr Blood Cancer
DOI: 10.1002/pbc.28866
sha: 36529cbf58592fcd6f36c1794709163b55c013c1
doc_id: 929522
cord_uid: br2xyzfs

nan

The American Society of Pediatric Hematology/Oncology

To the Editor:

A 5-month-old Caucasian male child presented with 36 h of persistent fever (temperature 40.2 • C). The patient was very irritable, with lip ulceration and perineal cellulitis. Complete blood counts showed nonregenerative anemia, leukopenia, and severe neutropenia (hemoglobin, 7.6 g/dL; leukocyte count, 1660/µL; neutrophil count, 150/µL; lymphocyte count, 1380/µL, platelet count, 157 × 10 3 /µL). A bone marrow aspiration showed hyperplasia of the granulocyte lineage with notably unbalanced maturation shifted toward promyelocytic and myelocytic forms, whereas neutrophils were very poorly represented (bone marrow smear differential count:70% granulocyte lineage cells including 8% myeloblasts, 16% promyelocytes, 23% myelocytes, 15% metamyelocytes, 3% neutrophils, as illustrated in Figure 1 

A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process. Lancet Child Adolesc Health

Congenital neutropenia in the era of genomics: classification, diagnosis, and natural history

COVID-19 and the clinical hematology laboratory

Hematologic parameters in patients with COVID-19 infection

Multisystem inflammatory syndrome in children rose and fell with the first wave of the COVID-19 pandemic in France